Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Synchronous telerehabilitation for people with elevated pulmonary artery pressure

Official title: The Effectiveness of Telerehabilitation in Patients With Elevated Pulmonary Artery Pressure

Run by Marmara University · NCT07535398 · Data updated 2026-11-12

This study will test whether a supervised, real-time telerehabilitation exercise program helps adults with high pulmonary artery pressure (sPAP ≥50 mmHg) improve breathing, stamina, and quality of life.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment12 (estimated)
SponsorMarmara University
Academic / other
Locations1 site (Tokat Province)
StatusRecruiting
StartedApril 2026
Main results expectedJune 2026
Study endsAugust 2026
Registry record updatedApril 29, 2026
Trial IDNCT07535398 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–65 with echocardiographic sPAP ≥50 mmHg who are clinically stable on cardiology follow-up, in WHO/NYHA class I–II, have internet access, and live with someone who can assist if needed.

Probably not a fit

Patients requiring oxygen therapy, with severe COPD, significant musculoskeletal or cognitive impairment, ongoing psychiatric treatment, or more advanced functional class are unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults with elevated pulmonary artery pressure identified by echocardiography (sPAP ≥50 mmHg) are randomly assigned to one of two 8-week programs delivered three times weekly for 30 minutes per session. One group receives synchronous (real-time video) aerobic, endurance, and strengthening exercises led by a clinician, while the comparison group performs breathing and posture exercises. The trial measures exercise capacity, dyspnea, fatigue, functional status, psychological status, pulmonary function, and quality of life before and after the intervention. The protocol targets clinically stable outpatients in WHO/NYHA class I–II who can participate in videoconference sessions.

Why it matters

Potential benefit: If successful, the program could improve exercise tolerance, reduce symptoms like breathlessness and fatigue, and make rehabilitation more accessible via home-based supervised sessions.

How similar studies have gone: Previous telerehabilitation programs in broader cardiopulmonary populations have shown benefits for function and symptoms, but synchronous telerehabilitation specifically for elevated pulmonary artery pressure remains limited and under-studied.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults aged 18 to 65 years
* Elevated pulmonary artery pressure identified by echocardiography, defined as systolic pulmonary artery pressure (sPAP) of 50 mmHg or higher
* Clinically stable and receiving medical treatment under cardiology follow-up World Health Organization functional class I or II
* New York Heart Association (NYHA) functional class I or II
* Living with a caregiver, family member, or another person who can provide assistance if needed
* Access to the internet and adequate visual, cognitive, and functional ability to participate in videoconference-based sessions
* Willing to participate and able to provide informed consent

Exclusion Criteria:

* Requirement for oxygen therapy
* Musculoskeletal problems limiting participation in exercise
* Ongoing treatment for psychiatric or psychological disorders
* Cognitive impairment based on Mini-Mental State Examination findings
* Severe chronic obstructive pulmonary disease (COPD)
* Other significant cardiac disease that may interfere with participation or assessment

Where it's running

  • Tokat Gaziosmanpaşa University
    Tokat Province, Turkey (Türkiye)
    Recruiting

Study contacts

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.